2 búsqueda de la palabra clave 'rheumatoid arthritis'

Concordance and correlation of activity indices in patients with rheumatoid arthritis in northwestern Colombia: A cross-sectional study / Ricardo César Restrepo Correa ; Carolina Muñoz Grajales ; Luis Fernando Pinto Peñaranda ; Javier Darío Márquez Hernández  

Público ISBD Título : Concordance and correlation of activity indices in patients with rheumatoid arthritis in northwestern Colombia: A cross-sectional study Tipo de documento : documento electrónico Autores : Ricardo César Restrepo Correa, ; Carolina Muñoz Grajales, ; Luis Fernando Pinto Peñaranda, ; Javier Darío Márquez Hernández, Fecha de publicación : 2018 Títulos uniformes : International Journal of Rheumatic Diseases Idioma : Inglés (eng) Palabras clave : Activity indices  concordance  correlation  rheumatoid arthritis Resumen : Aim: To determine the correlation and concordance between different clinimetric scores in patients with rheumatoid arthritis in two high-complexity reference centers in northwestern Colombia. Method: A cross-sectional study in adults diagnosed with rheumatoid arthritis was conducted according to the 2010 American College of Rheumatology and European League Against Rheumatism Classification Criteria, between January and June, 2013. The correlation was evaluated using Spearman’s correlation coefficient, and concordance with quadratic weighted kappa with the respective confidence intervals, for which patients were classified into different categories of disease activity. Results: One hundred patients were included, of whom 83% were women; 58 and 75% received methotrexate and glucocorticoids, respectively. Most individuals were in remission or low activity. High correlations between Disease Activity Score of 28 joints – erythrocyte sedimentation rate (DAS28-ESR) values with DAS28 C-reactive protein and Simple Disease Activity Index (SDAI) with Clinical Disease Activity Index (P Mención de responsabilidad : Ricardo Restrepo-Correa, Libia M Rodríguez-Padilla, Aura L Zapata-Castellanos, Andrea Ocampo, Juan J García, Carolina Muñoz-Grajales, Luis F Pinto-Peñaranda, Javier D Márquez-Hernández, Miguel A Mesa-Navas, Carlos J Velásquez-Franco Referencia : Int J Rheum Dis. 2018 Nov;21(11):1946-1954. DOI (Digital Object Identifier) : 10.1111/1756-185X.13227 PMID : 29152874 En línea : https://onlinelibrary.wiley.com/doi/abs/10.1111/1756-185X.13227 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4202 Concordance and correlation of activity indices in patients with rheumatoid arthritis in northwestern Colombia: A cross-sectional study [documento electrónico] / Ricardo César Restrepo Correa, ; Carolina Muñoz Grajales, ; Luis Fernando Pinto Peñaranda, ; Javier Darío Márquez Hernández,  . - 2018. Obra : International Journal of Rheumatic Diseases Idioma : Inglés (eng) Palabras clave : Activity indices  concordance  correlation  rheumatoid arthritis Resumen : Aim: To determine the correlation and concordance between different clinimetric scores in patients with rheumatoid arthritis in two high-complexity reference centers in northwestern Colombia. Method: A cross-sectional study in adults diagnosed with rheumatoid arthritis was conducted according to the 2010 American College of Rheumatology and European League Against Rheumatism Classification Criteria, between January and June, 2013. The correlation was evaluated using Spearman’s correlation coefficient, and concordance with quadratic weighted kappa with the respective confidence intervals, for which patients were classified into different categories of disease activity. Results: One hundred patients were included, of whom 83% were women; 58 and 75% received methotrexate and glucocorticoids, respectively. Most individuals were in remission or low activity. High correlations between Disease Activity Score of 28 joints – erythrocyte sedimentation rate (DAS28-ESR) values with DAS28 C-reactive protein and Simple Disease Activity Index (SDAI) with Clinical Disease Activity Index (P Mención de responsabilidad : Ricardo Restrepo-Correa, Libia M Rodríguez-Padilla, Aura L Zapata-Castellanos, Andrea Ocampo, Juan J García, Carolina Muñoz-Grajales, Luis F Pinto-Peñaranda, Javier D Márquez-Hernández, Miguel A Mesa-Navas, Carlos J Velásquez-Franco Referencia : Int J Rheum Dis. 2018 Nov;21(11):1946-1954. DOI (Digital Object Identifier) : 10.1111/1756-185X.13227 PMID : 29152874 En línea : https://onlinelibrary.wiley.com/doi/abs/10.1111/1756-185X.13227 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4202

Reserva

Reservar este documento

Ejemplares(1)

Código de barras	Número de Ubicación	Tipo de medio	Ubicación	Sección	Estado
DD000816	AC-2018-103	Archivo digital	Producción Científica	Artículos científicos	Disponible

Serious liver disease induced by infliximab / Alejandra María Restrepo Hamid  

Público ISBD Título : Serious liver disease induced by infliximab Tipo de documento : documento electrónico Autores : Alejandra María Restrepo Hamid, Fecha de publicación : 2007 Títulos uniformes : Clinical Rheumatology Idioma : Inglés (eng) Palabras clave : Adverse reactions  autoimmune hepatitis  cholestatic liver disease  infliximab  rheumatoid arthritis Resumen : Infliximab, a chimeric monoclonal antibody that binds the tumor necrosis factor α (TNFα), is used in the treatment of rheumatoid arthritis (RA) and Crohn’s disease (CD). Previous cases of significant secondary liver disease associated with infliximab treatment have been reported in patients with RA, CD, and psoriatic arthritis. Two additional patients with RA who developed a serious liver disease associated with infliximab treatment are reported here. A 39-year old RA patient was admitted with cholestatic liver disease after 8 months of treatment with infliximab. She had no history of hepatic diseases, exposure to hepatotoxic or illicit drugs, or alcohol abuse. A liver biopsy showed severe ductal proliferation with collapse and enucleation of the hepatocytes. Despite aggressive treatment with oral prednisolone, she developed hepatic failure. On the 45th day, a liver transplant was performed. The second patient, a 54-year old RA patient, was diagnosed with autoimmune hepatitis after 12 infliximab infusions. She fulfilled autoimmune hepatitis type 1 criteria. A liver biopsy disclosed an altered lobulillar structure with chronic inflammation and the formation of collagen bands. She was treated with prednisolone and azatioprine and a complete recovery was noted 1 month later. These cases should alert rheumatologists to the possibility of new adverse reactions (liver injury) associated with the use of TNFα blockers in an autoimmune setting. Mención de responsabilidad : Gabriel J. Tobon, Carlos Cañas, Juan-Jose Jaller, Juan-Carlos Restrepo & Juan-Manuel Anaya Referencia : Clin Rheumatol. 2007 Apr;26(4):578-81. DOI (Digital Object Identifier) : 10.1007/s10067-005-0169-y PMID : 16547695 En línea : https://link.springer.com/article/10.1007%2Fs10067-005-0169-y Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3450 Serious liver disease induced by infliximab [documento electrónico] / Alejandra María Restrepo Hamid,  . - 2007. Obra : Clinical Rheumatology Idioma : Inglés (eng) Palabras clave : Adverse reactions  autoimmune hepatitis  cholestatic liver disease  infliximab  rheumatoid arthritis Resumen : Infliximab, a chimeric monoclonal antibody that binds the tumor necrosis factor α (TNFα), is used in the treatment of rheumatoid arthritis (RA) and Crohn’s disease (CD). Previous cases of significant secondary liver disease associated with infliximab treatment have been reported in patients with RA, CD, and psoriatic arthritis. Two additional patients with RA who developed a serious liver disease associated with infliximab treatment are reported here. A 39-year old RA patient was admitted with cholestatic liver disease after 8 months of treatment with infliximab. She had no history of hepatic diseases, exposure to hepatotoxic or illicit drugs, or alcohol abuse. A liver biopsy showed severe ductal proliferation with collapse and enucleation of the hepatocytes. Despite aggressive treatment with oral prednisolone, she developed hepatic failure. On the 45th day, a liver transplant was performed. The second patient, a 54-year old RA patient, was diagnosed with autoimmune hepatitis after 12 infliximab infusions. She fulfilled autoimmune hepatitis type 1 criteria. A liver biopsy disclosed an altered lobulillar structure with chronic inflammation and the formation of collagen bands. She was treated with prednisolone and azatioprine and a complete recovery was noted 1 month later. These cases should alert rheumatologists to the possibility of new adverse reactions (liver injury) associated with the use of TNFα blockers in an autoimmune setting. Mención de responsabilidad : Gabriel J. Tobon, Carlos Cañas, Juan-Jose Jaller, Juan-Carlos Restrepo & Juan-Manuel Anaya Referencia : Clin Rheumatol. 2007 Apr;26(4):578-81. DOI (Digital Object Identifier) : 10.1007/s10067-005-0169-y PMID : 16547695 En línea : https://link.springer.com/article/10.1007%2Fs10067-005-0169-y Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3450

Reserva

Reservar este documento

Ejemplares(1)

Código de barras	Número de Ubicación	Tipo de medio	Ubicación	Sección	Estado
DD000018	AC-2007-005	Archivo digital	Producción Científica	Artículos científicos	Disponible